These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

384 related articles for article (PubMed ID: 17574163)

  • 21. Successful private-public funding of paediatric medicines research: lessons from the EU programme to fund research into off-patent medicines.
    Ruggieri L; Giannuzzi V; Baiardi P; Bonifazi F; Davies EH; Giaquinto C; Bonifazi D; Felisi M; Chiron C; Pressler R; Rabe H; Whitaker MJ; Neubert A; Jacqz-Aigrain E; Eichler I; Turner MA; Ceci A;
    Eur J Pediatr; 2015 Apr; 174(4):481-91. PubMed ID: 25241827
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Juvenile animal studies for the development of paediatric medicines: a description and conclusions from a European Medicines Agency workshop on juvenile animal testing for nonclinical assessors.
    Silva-Lima B; Due Theilade-Thomsen M; Carleer J; Vidal JM; Tomasi P; Saint-Raymond A
    Birth Defects Res B Dev Reprod Toxicol; 2010 Dec; 89(6):467-73. PubMed ID: 20632393
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The development of medicines for children. Part of a series on Pediatric Pharmacology, guest edited by Gianvincenzo Zuccotti, Emilio Clementi, and Massimo Molteni.
    Rocchi F; Tomasi P
    Pharmacol Res; 2011 Sep; 64(3):169-75. PubMed ID: 21376810
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The European Prader-Willi Syndrome Clinical Research Database: an aid in the investigation of a rare genetically determined neurodevelopmental disorder.
    Holland A; Whittington J; Cohen O; Curfs L; Delahaye F; Dudley O; Horsthemke B; Lindgren AC; Nourissier C; Sharma N; Vogels A
    J Intellect Disabil Res; 2009 Jun; 53(6):538-47. PubMed ID: 19457156
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Developing paediatric medicines: identifying the needs and recognizing the challenges.
    Ernest TB; Elder DP; Martini LG; Roberts M; Ford JL
    J Pharm Pharmacol; 2007 Aug; 59(8):1043-55. PubMed ID: 17725846
    [TBL] [Abstract][Full Text] [Related]  

  • 26. European survey on ethical and legal framework of clinical trials in paediatrics: results and perspectives.
    Altavilla A; Giaquinto C; Ceci A
    J Int Bioethique; 2008 Sep; 19(3):17-48, 121-2. PubMed ID: 19244940
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Better medicines for children].
    Brasseur D
    Rev Med Brux; 2006; 27 Spec No():Sp25-8. PubMed ID: 21818889
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Are children getting the right drugs?].
    Bratlid D
    Tidsskr Nor Laegeforen; 2005 Dec; 125(23):3290-2. PubMed ID: 16327857
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Superior efficacy of new medicines?
    van Luijn JC; Gribnau FW; Leufkens HG
    Eur J Clin Pharmacol; 2010 May; 66(5):445-8. PubMed ID: 20224944
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Developing a European framework for research on children's medicines: an examination of the proposed EU regulation on medicinal products for paediatric use.
    Seyberth HW; Demotes-Mainard J; Wrobel P
    Pediatr Nephrol; 2005 Nov; 20(11):1537-40. PubMed ID: 16167134
    [No Abstract]   [Full Text] [Related]  

  • 31. Extrapolation in the development of paediatric medicines: examples from approvals for biological treatments for paediatric chronic immune-mediated inflammatory diseases.
    Stefanska AM; Distlerová D; Musaus J; Olski TM; Dunder K; Salmonson T; Mentzer D; Müller-Berghaus J; Hemmings R; Veselý R
    Arch Dis Child; 2017 Oct; 102(10):952-957. PubMed ID: 28554892
    [TBL] [Abstract][Full Text] [Related]  

  • 32. EU initiatives for research involving children.
    Donnelly F
    Eur J Pediatr; 2008 Jul; 167(7):837-8. PubMed ID: 18253749
    [TBL] [Abstract][Full Text] [Related]  

  • 33. More medicines for children: impact of the EU paediatric regulation.
    Nordenmalm S; Tomasi P; Pallidis C
    Arch Dis Child; 2018 Jun; 103(6):557-564. PubMed ID: 29490933
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Better medicines for children: European measures].
    Broekmans AW
    Ned Tijdschr Geneeskd; 2008 Aug; 152(35):1945; author reply 1945. PubMed ID: 18808086
    [No Abstract]   [Full Text] [Related]  

  • 35. Progress review of the European Paediatric Regulatory Framework after six years of implementation.
    Mentzer D
    Int J Pharm; 2014 Aug; 469(2):240-3. PubMed ID: 24613178
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The status of paediatric medicines initiatives around the world--What has happened and what has not?
    Hoppu K; Anabwani G; Garcia-Bournissen F; Gazarian M; Kearns GL; Nakamura H; Peterson RG; Sri Ranganathan S; de Wildt SN
    Eur J Clin Pharmacol; 2012 Jan; 68(1):1-10. PubMed ID: 21732178
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The EU paediatric regulation: still a large discrepancy between therapeutic needs and approved paediatric investigation plans.
    Wimmer S; Rascher W; McCarthy S; Neubert A
    Paediatr Drugs; 2014 Oct; 16(5):397-406. PubMed ID: 25056717
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Juvenile animal studies in the development of pediatric medicines: experience from European medicines and pediatric investigation plans.
    Duarte DM; Silva-Lima B
    Birth Defects Res B Dev Reprod Toxicol; 2011 Aug; 92(4):353-8. PubMed ID: 21594973
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Excipients: regulatory aspects].
    Artiges A
    Therapie; 1999; 54(1):15-9. PubMed ID: 10216417
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The European Medicines Agency: an overview of its mission, responsibilities, and recent initiatives in cancer drug regulation.
    Pignatti F; Gravanis I; Herold R; Vamvakas S; Jonsson B; Marty M
    Clin Cancer Res; 2011 Aug; 17(16):5220-5. PubMed ID: 21844037
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 20.